Citation Impact
Citing Papers
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Armed Antibodies Targeting the Mucin Repeats of the Ovarian Cancer Antigen, MUC16, Are Highly Efficacious in Animal Tumor Models
2007
An enzymatic toolkit for selective proteolysis, detection, and visualization of mucin-domain glycoproteins
2020 StandoutNobel
High-dose chemotherapy with autologous bone marrow transplantation in patients with refractory ovarian cancer
1989
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Mucins in cancer: function, prognosis and therapy
2009
The epithelial mucin, MUC1, of milk, mammary gland and other tissues
1995
The health consequences of smoking: Cancer
1992
Interleukin‐13 receptor α2 chain
2006
Physical Principles of Membrane Shape Regulation by the Glycocalyx
2019 StandoutNobel
Role of ERas in promoting tumour-like properties in mouse embryonic stem cells
2003 StandoutNatureNobel
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
2014
MULTIMODAL APPROACH TO SCREENING FOR OVARIAN CANCER
1988
A genetic model for colorectal tumorigenesis
1990 Standout
Smad-dependent and Smad-independent pathways in TGF-β family signalling
2003 StandoutNature
Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study
1989
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Regulated portals of entry into the cell
2003 StandoutNature
Transvaginal sonography as a screening method for ovarian cancer a report of the first 1000 cases screened
1990
ENDOTHELIN: AN IMPORTANT FACTOR IN ACUTE RENAL FAILURE?
1988 StandoutNobel
Linkage of a prion protein missense variant to Gerstmann–Sträussler syndrome
1989 StandoutNatureNobel
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Disabled‐2 Colocalizes with the LDLR in Clathrin‐Coated Pits and Interacts with AP‐2
2001
Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer
1990
Epithelial Mucin Genes
1995
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma
1989
The search for the causes of breast and colon cancer
1989 Nature
The joint effect of risk factors on endometrial cancer
1988
The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway
2001
Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.
1991
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer
1993
Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: An updated review
1993
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
2000 Standout
Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifyingGolgi/post-Golgi compartments
2015
Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125
2003
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
2010
Influence of non‐contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark
1988
Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk
1989
Oncofetal reprogramming in tumour development and progression
2022
True
2000
The follow-up of ovarian cancer
2003
Mucins in cancer: protection and control of the cell surface
2003
Cancer-related inflammation
2008 StandoutNature
Endometrioid carcinoma of the ovary presenting with an enlarged inguinal lymph node without evidence of abdominal carcinomatosis
1992
The detection, treatment, and biology of epithelial ovarian cancer
2010
Comparison of Effect Estimates from a Meta-Analysis of Summary Data from Published Studies and from a Meta-Analysis Using Individual Patient Data for Ovarian Cancer Studies
1997
Estrogen replacement therapy and the risk of endometrial cancer: Remaining controversies
1990
Use of Replacement Estrogens and the Risk of Myocardial Infarction
1990
Cancer of the Ovary
2004 Standout
Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer
2017
Atroposelective Total Synthesis of Axially Chiral Biaryl Natural Products
2010 Standout
Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.
1993 StandoutNobel
Homologies Between Signal Transducing G Proteins and ras Gene Products
1984 StandoutScienceNobel
The Risk of Endometrial Neoplasia and Treatment with Estrogens and Estrogen ‐ Progestogen Combinations: First results of a cohort study after one to four completed years of observation
1986
p53 Mutations in Human Cancers
1991 StandoutScience
Renal Hemodynamics in Acute Renal Failure
1980
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogene
1987 StandoutScience
Phenotypic consequences of lung-specific inducible expression of FGF-3
2001 StandoutNobel
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
1983 Standout
Norepinephrine-induced acute renal failure: A reversible ischemic model of acute renal failure
1978
THE MOLECULAR GENETICS OF CELLULAR ONCOGENES
1984
The Steroid and Thyroid Hormone Receptor Superfamily
1988 StandoutScience
Isolation of the proto-oncogene c-myb from D. melanogaster
1985 StandoutNobel
Inositol trisphosphate, a novel second messenger in cellular signal transduction
1984 StandoutNature
Biological properties of human c-Ha-ras1 genes mutated at codon 12
1984 Nature
The Effects of Estrogens and Progestogens on the Endometrium
1987
CA125 in Ovarian Cancer
2007
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
1985 Standout
The Disabled 1 Phosphotyrosine-Binding Domain Binds to the Internalization Signals of Transmembrane Glycoproteins and to Phospholipids
1999
Structural Determinants of Ion Flow Through Recombinant Glutamate Receptor Channels
1991 StandoutScienceNobel
A novel ras-related gene family
1985 StandoutNobel
Binding of F-spondin to amyloid-β precursor protein: A candidate amyloid-β precursor protein ligand that modulates amyloid-β precursor protein cleavage
2004 StandoutNobel
Surgery for common epithelial tumors of the ovary
1981
Staging Laparotomy in Early Ovarian Cancer
1983
Biological and biochemical properties of human rasH genes mutated at codon 61
1986
The epidemiology of endometrial cancer in young women
1983
Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma.
1989 StandoutNobel
Survival among women with endometrial cancer: A comparison of estrogen users and nonusers
1982
A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA
1985 StandoutNobel
Cellular transforming genes and oncogenesis
1984
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
Highly lytic CD8+, alpha beta T-cell receptor cytotoxic T cells with major histocompatibility complex (MHC) class I antigen-directed cytotoxicity in beta 2-microglobulin, MHC class I-deficient mice.
1993
Effects of Estrogens and Progestins on the Biochemistry and Morphology of the Postmenopausal Endometrium
1981
The Molecular Genetics of Cancer
1987 StandoutScienceNobel
Deduced primary structure of the alpha subunit of the GTP-binding stimulatory protein of adenylate cyclase.
1986 StandoutNobel
The progesterone receptor gene maps to human chromosome band 11q13, the site of the mammary oncogene int-2.
1987
Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study
1986
A cellular gene encodes scrapie PrP 27-30 protein
1985 StandoutNobel
Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs.
1995 StandoutNobel
A comparison of estrogen use by women with endometrial cancer, gynecologic disorders, and other illnesses
1981
Interfacing Carbon Nanotubes with Living Cells
2006 StandoutNobel
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
1989 StandoutScience
Oncogene v-src transforms and establishes embryonic rodent fibroblasts but not diploid human fibroblasts.
1988 StandoutNobel
Addictive Drugs: The Cigarette Experience
1992 StandoutScienceNobel
Characterization of two members of the rho gene family from the yeast Saccharomyces cerevisiae.
1987 StandoutNobel
Transient up-regulation of P2Y2nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes
1997 StandoutNobel
Noncovalent Cell Surface Engineering: Incorporation of Bioactive Synthetic Glycopolymers into Cellular Membranes
2008 StandoutNobel
Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p21
1984
Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
1999 StandoutNobel
Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture
1985 StandoutNatureNobel
Works of Robert C. Knapp being referenced
Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas.
1984
Clear cell adenocarcinoma of the ovary: A clinical analysis and comparison with serous carcinoma
1989
Molecular Cloning of Differentially Expressed Genes in Human Epithelial Ovarian Cancer
1994
The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma
1992
Long-Term Follow-up of the Stockholm Screening Study on Ovarian Cancer
2000
Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses. Discrimination of benign from malignant disease
1988
Characterization of Human Ovarian Surface Epithelial Cells Immortalized by Human Papilloma Viral Oncogenes (HPV-E6E7 ORFs)
1995
Antiproliferative effect of gossypol and its optical isomers on human reproductive cancer cell lines
1989
Ovarian Clear Cell Carcinoma
1989
CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer Patients
1986
Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer
1985
Recent and Past Use of Conjugated Estrogens in Relation to Adenocarcinoma of the Endometrium
1980
Lymphatic drainage of the peritoneal cavity and its significance in ovarian cancer
1974
Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms
1983
Cigarette Smoking and the Risk of Endometrial Cancer
1985
A Radioimmunoassay Using a Monoclonal Antibody To Monitor the Course of Epithelial Ovarian Cancer
1984
The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer
1986
Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell Types
1983
Prolonged Unilateral Acute Renal Failure Induced by Intra-arterial Norepinephrine Infusion in the Dog
1972
RISK FACTORS FOR BREAST CANCER
1983
Elevated serum concentrations of CA-125 in patients with advanced endometriosis
1986
CA125 antigen levels in obstetric and gynecologic patients.
1984
Factors Affecting the Association of Oral Contraceptives and Ovarian Cancer
1982
Somatic Activation of ras K Gene in a Human Ovarian Carcinoma
1984 Science
Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer.
1984
Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinoma
1985
Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma
1985
Aortic lymph node metastases in early ovarian cancer
1974
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix
1984
Decreased Risk of Endometrial Cancer among Oral-Contraceptive Users
1980
Co‐expression of human cancer‐associated epitopes on mucin molecules
1987
Risk of Localized and Widespread Endometrial Cancer in Relation to Recent and Discontinued Use of Conjugated Estrogens
1985
Reactivity of a monoclonal antibody with human ovarian carcinoma.
1981
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen
1984
Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125
1983